How do you test for leaky gut at home, and what can a result actually tell you?
The short answer
You can collect a sample at home for some tests sold as leaky gut tests, mainly urine sugar tests, zonulin tests and food IgG panels, but none of them diagnoses leaky gut. A Mayo Clinic review found no validated clinical test or gold standard, widely used zonulin kits do not detect zonulin, and food IgG reflects exposure, not intolerance.
Search for “leaky gut” and the ads that follow are often for tests: a urine kit you mail back, a zonulin blood or stool test, a blood panel of foods your body supposedly “reacts” to. One lab’s urine kit is described as helping “diagnose malabsorption and intestinal permeability/leaky gut” (kit patient instructions, 2026). The research picture is less simple, and more useful. This page explains what each test family actually measures, what a result can and cannot tell you, and what a doctor is likely to test for instead. If you want the background on intestinal permeability itself, start with our explainer on what leaky gut is and how much of the online version is real.
How do you test for leaky gut at home?
You can collect samples at home for some tests sold as leaky gut tests, but no home test can diagnose leaky gut, because no validated clinical diagnostic test for it exists. A 2019 review in Gut by Mayo Clinic gastroenterologist Michael Camilleri concludes there are “no validated clinical diagnostic tests” for gut barrier function (Camilleri, 2019). What home kits offer is sample collection: you drink a sugar solution and collect urine, give a blood or stool sample, and a lab reports a number.
The tests marketed this way fall into three families:
- Urine sugar tests (lactulose and mannitol). The patient instructions for one commercially sold kit list the collection location as “at home”: you fast, drink a lactulose and mannitol solution, collect all your urine for 6 hours, and ship it to the lab, with results released to the ordering provider (kit patient instructions, 2026).
- Zonulin tests. Zonulin is a protein promoted as a blood or stool marker of a leaky barrier. Researchers have shown that widely used commercial zonulin assays do not detect the protein they are named for (Ajamian et al., 2019).
- Food IgG panels. These screen blood for antibodies to hundreds of foods, a market a European allergy task force described as growing. The same task force says food-specific IgG4 reflects exposure to food, not allergy or intolerance (Stapel et al., 2008).
Only the first family measures permeability directly, and even that one has real limits, covered below.
How is leaky gut diagnosed?
Leaky gut is not diagnosed as a condition in standard medical practice; doctors instead test for the specific diseases known to damage the gut barrier. The Camilleri review states there is “no current gold standard” with clear performance characteristics for barrier tests, that the available methods “actually measure very different endpoints,” and that their clinical significance “is unclear” (Camilleri, 2019). In research settings, permeability is measured with sugar absorption tests, with biopsy tissue tested in the lab, and with endoscopic techniques such as confocal endomicroscopy and mucosal impedance.
In everyday care, the workup for gut symptoms looks for named conditions. Celiac disease, for example, is typically diagnosed with blood antibody tests and small-intestine biopsies taken during an upper endoscopy (NIDDK). That is the practical answer to “how is leaky gut diagnosed”: by finding, or ruling out, conditions such as celiac or Crohn’s disease, where the Camilleri review describes barrier dysfunction as uncontroversial (Camilleri, 2019).
What do the different leaky gut tests actually measure?
Each test measures something different, and only one of them measures permeability directly. The table below sets them side by side.
| Attribute | What it measures | Validation status | Source |
|---|---|---|---|
| Urine sugar test (lactulose with mannitol, rhamnose or sucralose) | How much of swallowed, non-metabolized sugars appears in urine over set time windows | Research tool; normal values uncertain and procedure not standardized | Camilleri 2019; Khoshbin 2021 |
| Serum or stool zonulin (commercial kits) | Whatever protein the kit’s antibodies bind; shown not to be pre-haptoglobin 2, the protein identified as zonulin | Commercial assays shown not to detect zonulin; poor correlation with sugar tests | Scheffler 2018; Ajamian 2019; Massier 2021 |
| Food IgG or IgG4 panels | Antibodies (IgG4 in the cited report) to food proteins, which indicate repeated exposure to those foods | Not recommended for diagnosing food allergy or intolerance by a European allergy task force | Stapel 2008 |
| Biopsy tissue tested in the lab | How easily probe molecules cross a tissue sample, or its tight-junction proteins | Research setting; the tissue loses nerve inputs that regulate the barrier in the body | Camilleri 2019 |
| Endoscopic techniques (confocal endomicroscopy, mucosal impedance) | Barrier changes seen or measured during an endoscopy | Specialist and research use, not a home or routine test | Camilleri 2019 |
| Celiac antibody blood tests and biopsy | Antibodies that are often raised in untreated celiac disease, confirmed by tissue | Standard clinical diagnosis for a specific disease | NIDDK |
| Faecal calprotectin | A stool marker used to help tell inflammatory bowel disease from IBS | Recommended by NICE as an option for specific patient groups | NICE HTG320 |
The pattern is clear. The tests that are validated answer narrower questions (“is this celiac disease?”, “is this likely IBD or IBS?”). The tests marketed as leaky gut tests either measure permeability with research-grade caveats or do not measure permeability at all.
What can a lactulose-to-mannitol test tell you, and what can’t it?
A urine sugar test can show how much of two swallowed sugars reached your urine on one day, but there are no agreed normal values that turn that number into a diagnosis. The logic is that the smaller sugar, mannitol, is absorbed far more readily than the larger lactulose, so a rising share of lactulose suggests a leakier barrier; the Camilleri review notes the absorption ratio differs 30- to 100-fold between the two. It notes that urine collected over 0 to 2 hours mostly reflects the small intestine and urine collected over 8 to 24 hours almost entirely reflects the colon, and it concludes these tests “still have limited validity based on uncertainty of the normal values, lack of standardization of test procedure, and lack of validation” (Camilleri, 2019).
Diet is one complication. A 2021 Mayo Clinic study that gave 60 healthy adults standardized meals found ordinary mannitol already in the urine of every participant before they took the test sugars, enough that the authors concluded standard mannitol cannot be used as the probe and a carbon-13 labeled form is preferred (Khoshbin et al., 2021). The same study found results varied widely between healthy people, with a median coefficient of variation of 76.5%. Kit instructions likewise list foods to avoid on test day, including fruit, dairy, honey and mushrooms, and medicines to avoid for 72 hours beforehand, including aspirin and anti-inflammatory drugs, while telling patients not to stop prescription medications without consulting their provider (kit patient instructions, 2026).
Lab method is another. A 2019 study of the lactulose-mannitol test notes that “different laboratories do the test by different methods, which make the results incomparable between laboratories” (Musa et al., 2019).
None of this means the test is useless in research. In a prospective study of 1,420 asymptomatic first-degree relatives of people with Crohn’s disease, an abnormal baseline lactulose-to-mannitol ratio (above 0.03) was associated with about three times the risk of later developing Crohn’s (hazard ratio 3.03) (Turpin et al., 2020). That is a finding about risk across a large, genetically predisposed group, not a way to read one person’s home result.
Is a zonulin test accurate?
The evidence says widely used commercial zonulin tests do not measure zonulin, so a “high zonulin” result cannot be read as proof of a leaky gut. Zonulin was identified as pre-haptoglobin 2, but a 2018 study that measured serum zonulin in 376 people with a widely used commercial ELISA found, in follow-up lab tests, that the kit did not detect purified pre-haptoglobin 2 and instead recognized other proteins, including properdin (Scheffler et al., 2018).
An independent 2019 study from Monash University tested two commercial serum zonulin assays and found their top matches were other proteins, including haptoglobin and complement C3. The authors concluded that current commercial assays “are not detecting the actual protein” and advised caution in using serum zonulin as a marker of barrier integrity (Ajamian et al., 2019).
A 2021 letter in Gut from Leipzig researchers went further: measurements with these commercial kits “do not reflect actual zonulin levels, but concentrations of unknown proteins,” they correlate only poorly with sugar permeability tests, and researchers were urged to use dual-sugar tests instead (Massier et al., 2021). The same letter notes a separate study in which serum zonulin failed to identify IBS, functional dyspepsia or non-coeliac wheat sensitivity. The authors are careful to say this does not rule out zonulin as a real regulator of the barrier; the problem is the test, not the biology.
Do food sensitivity (IgG) tests show leaky gut?
No. Food IgG panels measure antibodies to foods you have eaten, and allergy specialists say those antibodies are a sign of repeated exposure to a food, not of allergy or intolerance. A European Academy of Allergy and Clinical Immunology task force noted that many samples show positive IgG4 results without matching symptoms, that there are no controlled studies on their diagnostic value, and that food-specific IgG4 indicates exposure and tolerance. It concluded that IgG4 testing to foods “should not be performed in case of food-related complaints” (Stapel et al., 2008).
The reasoning that links these panels to leaky gut runs like this: food proteins escape through a leaky barrier, the immune system makes antibodies, so a long list of positives must mean a leaky gut. The task force’s reading is the opposite. A long list of positives mostly reflects foods the immune system has met repeatedly, which points to diet, not to a damaged barrier.
What tests will a doctor actually run for gut symptoms?
A doctor is likely to test for specific, treatable conditions rather than for “leaky gut,” with the choice depending on your symptoms and history. For suspected celiac disease, that means antibody blood tests while you are still eating gluten, followed by small-intestine biopsies at endoscopy; NIDDK notes that starting a gluten-free diet before testing can affect the results (NIDDK).
For adults with recent-onset lower bowel symptoms being considered for specialist assessment, England’s NICE recommends faecal calprotectin as an option to help distinguish inflammatory bowel disease from IBS, provided cancer is not suspected (NICE HTG320).
IBS is a useful example of how permeability fits in. A 2021 systematic review of 66 studies found barrier dysfunction in a significant proportion of adult IBS studies, most clearly in diarrhea-predominant and post-infectious IBS (Hanning et al., 2021). That is a pattern across groups of patients; the review is not a case for using a permeability test to diagnose any one person.
Is an at-home leaky gut test worth it?
For most people, an at-home leaky gut test answers a question that research has not yet learned how to ask clinically, so the result is hard to act on. A urine sugar result has no agreed normal range, a zonulin result likely reflects other proteins, and a food IgG panel mostly mirrors your diet, based on the sources above. None of them can tell you why your gut might be more permeable, which is the part that matters for treatment.
There is a social dynamic worth naming here. If someone builds a plan on a “leaky” result, whether an elimination diet, a supplement stack or a peptide such as BPC-157, the plan inherits every weakness of the test. Our review of BPC-157 for IBS and IBD shows how thin the human evidence is for that last step. A test that cannot diagnose a condition is a weak foundation for a treatment plan built around that condition.
If you are dealing with ongoing gut symptoms, the more useful move is to describe them clearly to a clinician and ask which specific conditions they want to rule out, and with which tests. If peptides or “gut-healing” protocols come up in that conversation, our list of questions to ask your doctor about peptides can help you get straight answers.
The bottom line on leaky gut tests
Intestinal permeability is real and measurable in research, but no test, at home or in a clinic, is validated to diagnose “leaky gut.” The urine sugar test measures permeability with uncertain normal values and lab-to-lab differences; commercial zonulin tests have been shown not to detect zonulin; and food IgG panels measure exposure, not allergy or intolerance. The tests that do lead to diagnoses, such as celiac antibodies with biopsy or faecal calprotectin, look for specific diseases, including ones in which barrier dysfunction is well documented. That is where the evidence points if you want answers.
Educational information only, not medical advice. Every research statement on this page is sourced to the peer-reviewed literature, guidance and documents linked above, checked October 12, 2026. This page is drafted with AI assistance and fact-checked against the cited primary sources before publication.
Sources (12)
Advertising disclosure: links marked "Paid link" go to Bodybuilding Peptides (trybbpeptides.com), an affiliate destination, and Gut & Immune may earn a commission if you buy there. Our coverage is independent of that relationship, and nothing on this page is medical or legal advice.